Indications that the Federal Reserve would continue its bond buying program through the end of the year boosted the markets to a sharply higher open with the Dow soaring 107 points to 15,399. Nasdaq surged 34 points to 3554.
On the upside
Rockwell Medical (Nasdaq: RMTI) reported positive results from a Phase 3 study of its iron deficiency treatment SFP.
Celgene (Nasdaq: CELG) reported upbeat results from a Phase III study of its multiple myeloma drug Revlimid.
The Higher Learning Commission reaffirmed the accreditation of Apollo Group's (Nasdaq: APOL) University of Phoenix.
On the downside
SemiLEDs (Nasdaq: LEDS) widened third quarter losses as revenue dropped.
Silicon Valley Bank requested that a receiver be appointed to collect a loan made to Alvarion (Nasdaq: ALVR).
Merrimack Pharmaceuticals (Nasdaq: MACK) will offer $50 million worth of common stock and $75 million worth of convertible senior notes.
In the broad market, advancing issues outpaced decliners by a margin of nearly 8 to 1 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 index climbed 14 points to 1666.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here